INCLINE VILLAGE, Nev.
May 30, 2013
/PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that
John P. McLaughlin
, the company's president and chief executive officer, will present at the following upcoming conferences.
Jefferies 2013 Global Healthcare Conference
Thursday, June 6, 2013
9:30 a.m. ET
New York City
Goldman Sachs 34 th Annual Global Healthcare Conference
Tuesday, June 11, 2013
10:40 a.m. PT
Rancho Palos Verdes, CA
To access the live and subsequently archived webcasts of the presentations, go to the Company's website at
and go to "Events and Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. The archived webcast will be available for seven days following each presentation.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.